About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Infinimmune Appoints Dr. Tim Sullivan as Chief Business Officer

Infinimmune, a biotechnology company pioneering new methods for antibody drug discovery and development, announced today the appointment of Tim Sullivan, Ph.D., as Chief Business Officer. In this newly created role, Dr. Sullivan, who has decades of experience as a senior executive in the biotechnology and pharmaceutical industry, will be responsible for corporate and business development initiatives, as well as corporate and product strategic planning.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240903196986/en/

Dr. Tim Sullivan, Chief Business Officer, Infinimmune (Photo Credit: Infinimmune)

Dr. Tim Sullivan, Chief Business Officer, Infinimmune (Photo Credit: Infinimmune)

“We’re thrilled to have Tim lead Infinimmune’s business development efforts, driving strategic growth initiatives and fostering key partnerships to advance our mission of developing fully human antibody therapies,” said Wyatt McDonnell, CEO & Co-Founder, Infinimmune. “His deep industry knowledge and proven track record in business development and strategy will be invaluable as we continue to expand our capabilities and deliver innovative antibody therapies to patients.”

“I am excited to join Infinimmune at such a dynamic time. The company’s commitment to pioneering advances in antibody development is truly inspiring, and I look forward to contributing to its continued success by leading our business development initiatives,��� said Sullivan.

Prior to joining Infinimmune, Dr. Sullivan served as Chief Business Officer at Spring Discovery, a biotech company, where he executed partnerships with multiple groups, including Gilead and the Gates Foundation, and built an efficient engine for identifying new partnership opportunities. He was also Vice President of Business Development at Arcus Biosciences, where he played a pivotal role in expanding the company’s strategic partnerships and pipeline. Prior to Arcus, he was the Senior Director of External R&D Innovation at Pfizer, where he was instrumental in identifying and securing external collaborations that fueled the company’s innovation pipeline.

He also held the position of Director at Takeda, where he was responsible for sourcing and integrating cutting-edge technologies and therapeutic assets. Additionally, he served as Research Director at ChemoCentryx, contributing to the advancement of novel immunology-based therapies.

Dr. Sullivan received his Ph.D. in Molecular and Cell Biology at the University of California, Berkeley, where he trained under Jim Allison. He also received a B.A in Psychology and Biology from the University of Notre Dame.

About Infinimmune

Infinimmune is a biotechnology company pioneering a novel approach to antibody drug discovery and development. Founded by a world-class, multidisciplinary team of scientists and technologists, Infinimmune is reinventing antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system. These truly human antibodies are designed to drug new and existing targets with improved safety and efficacy. Infinimmune will deploy its holistic approach to build its own pipeline of drug candidates and partner with pharmaceutical companies to advance their antibody programs, fill their pipelines, and reach new patients and new indications. To learn more, visit infinimmune.com and follow us on LinkedIn and @infinimmune.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.